36.1 C
Delhi
Friday, March 29, 2024

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

Ten killed as passenger taxi falls into gorge in J&K’s Ramban, 2 identified

Jammu: At least ten passengers died when a passenger taxi they were travelling in skidded off and plunged...

UP: Mayawati, Akhilesh demand high-level probe into Mukhtar’s death

Lucknow: Bahujan Samaj Party (BSP) supremo Mayawati and Samajwadi Party (SP) president on Friday demanded a high-level probe...

Trump speaks at wake of fallen NYPD officer, calls for return to ‘law and order’

Washington: Former President Donald Trump attended the wake of fallen NYPD officer Jonathan Diller on Thursday and called...

Palestinian death toll in Gaza Strip rises to 32,552: ministry

Gaza: The Palestinian death toll in the Gaza Strip has risen to 32,552, the Hamas-run Health Ministry said...